Moderna Inc. said it has a “next-generation COVID-19 vaccine," which it wants to use as part of a combination COVID-flu treatment. The biotech firm said Tuesday that the shot showed a better ...

The contract, signed in the final days of the Biden administration, is designed to help Moderna develop and test the safety and efficacy of vaccines to protect against five subtypes of influenza ...

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?

Shares of Moderna (MRNA), Pfizer (PFE) and Novavax (NVAX) all gained Friday, a broadly downbeat session that saw the S&P 500 slide 1.7%. Moderna was the biggest gainer on the benchmark index ...

(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.

Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the company will shift its focus ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

#TeamPfizer and #TeamModerna are two of the captions often found next to selfies of proud newly vaccinated people on social media. And both groups do have a reason to celebrate as the two mRNA ...